BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18041036)

  • 1. Porous silicon surfaces: a candidate substrate for reverse protein arrays in cancer biomarker detection.
    Ressine A; Corin I; Järås K; Guanti G; Simone C; Marko-Varga G; Laurell T
    Electrophoresis; 2007 Dec; 28(23):4407-15. PubMed ID: 18041036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macro-/nanoporous silicon as a support for high-performance protein microarrays.
    Ressine A; Ekström S; Marko-Varga G; Laurell T
    Anal Chem; 2003 Dec; 75(24):6968-74. PubMed ID: 14670060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse-phase versus sandwich antibody microarray, technical comparison from a clinical perspective.
    Järås K; Ressine A; Nilsson E; Malm J; Marko-Varga G; Lilja H; Laurell T
    Anal Chem; 2007 Aug; 79(15):5817-25. PubMed ID: 17605470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility of surfaces for antibody microarrays: design of macroporous silicon substrates.
    Steinhauer C; Ressine A; Marko-Varga G; Laurell T; Borrebaeck CA; Wingren C
    Anal Biochem; 2005 Jun; 341(2):204-13. PubMed ID: 15907865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
    Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
    Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications of novel monoclonal antibodies specific for synuclein-gamma in evaluating its levels in sera and cancer tissues from colorectal cancer patients.
    Liu C; Guo J; Qu L; Bing D; Meng L; Wu J; Shou C
    Cancer Lett; 2008 Sep; 269(1):148-58. PubMed ID: 18586385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced or absent cyclin H expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
    Bavi P; Abubaker J; Hussain A; Sultana M; Al-Dayel F; Uddin S; Al-Kuraya KS
    Hum Pathol; 2008 Jun; 39(6):885-94. PubMed ID: 18400256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porous silicon protein microarray technology and ultra-/superhydrophobic states for improved bioanalytical readout.
    Ressine A; Marko-Varga G; Laurell T
    Biotechnol Annu Rev; 2007; 13():149-200. PubMed ID: 17875477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Robust estimation of protein expression ratios with lysate microarray technology.
    Mircean C; Shmulevich I; Cogdell D; Choi W; Jia Y; Tabus I; Hamilton SR; Zhang W
    Bioinformatics; 2005 May; 21(9):1935-42. PubMed ID: 15647295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of porous silicon substrate for well-characterised sensitive DNA chip implement.
    Bessueille F; Dugas V; Vikulov V; Cloarec JP; Souteyrand E; Martin JR
    Biosens Bioelectron; 2005 Dec; 21(6):908-16. PubMed ID: 16257660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using continuous porous silicon gradients to study the influence of surface topography on the behaviour of neuroblastoma cells.
    Khung YL; Barritt G; Voelcker NH
    Exp Cell Res; 2008 Feb; 314(4):789-800. PubMed ID: 18054914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
    Voduc D; Nielsen TO; Cheang MC; Foulkes WD
    Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attachment and response of human fibroblast and breast cancer cells to three dimensional silicon microstructures of different geometries.
    Nikkhah M; Strobl JS; Agah M
    Biomed Microdevices; 2009 Apr; 11(2):429-41. PubMed ID: 19058013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of hydrophobic proteins as biomarker candidates for colorectal cancer.
    Alvarez-Chaver P; Rodríguez-Piñeiro AM; Rodríguez-Berrocal FJ; Martínez-Zorzano VS; Páez de la Cadena M
    Int J Biochem Cell Biol; 2007; 39(3):529-40. PubMed ID: 17084656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteome analysis of membrane fractions in colorectal carcinomas by using 2D-DIGE saturation labeling.
    Alfonso P; Cañamero M; Fernández-Carbonié F; Núñez A; Casal JI
    J Proteome Res; 2008 Oct; 7(10):4247-55. PubMed ID: 18707159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
    Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
    Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.